GLIOBLASTOMA MULTIFORME OF BRAIN
Clinical trials for GLIOBLASTOMA MULTIFORME OF BRAIN explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME OF BRAIN trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME OF BRAIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cold sore virus Re-Injected into brain tumors in search for new treatment
Disease control TerminatedThis early-stage trial tested the safety of giving a second dose of an experimental treatment called C134 to adults with recurrent malignant brain tumors. C134 is a genetically modified cold sore virus designed to infect and kill tumor cells when injected directly into the brain.…
Matched conditions: GLIOBLASTOMA MULTIFORME OF BRAIN
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Old drug, new target: can a fungus fighter slow brain cancer?
Knowledge-focused TerminatedThis small, early-stage study aimed to see if a common antifungal drug called posaconazole could get into brain tumors at high enough levels to potentially stop cancer cells from growing. Researchers gave the drug to a few adults with a type of aggressive brain cancer before thei…
Matched conditions: GLIOBLASTOMA MULTIFORME OF BRAIN
Phase: EARLY_PHASE1 • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
Old drug, new target: can a common pill fight deadly brain cancer?
Knowledge-focused TerminatedThis very early study aimed to see if ketoconazole, a drug used for fungal infections, could get into brain tumors at high enough levels to potentially stop cancer cell growth. Researchers planned to measure drug levels directly in the tumor tissue of a small number of adults wit…
Matched conditions: GLIOBLASTOMA MULTIFORME OF BRAIN
Phase: EARLY_PHASE1 • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC